Peer-reviewed article
Delivery room practices for extremely preterm infants: the harms of the gestational age label
Interventions for extremely preterm infants bring up many ethical questions. To answer these questions, data are needed. The investigators of the Epipage-2 study have conducted a rigorous investigation: they report outcomes for all 2145…
Interventions for extremely preterm infants bring up many ethical questions. To answer these questions, data are needed. The investigators of the Epipage-2 study have conducted a rigorous investigation: they report outcomes for all 2145 neonates born between 22 and 26 weeks of gestational age (GA) in France in 2011.1 Their primary outcome measure was the provision of life sustaining interventions in the delivery room and survival statistics. They show that, over a year in France, only one baby born before 24 weeks GA survived to neonatal intensive care unit (NICU) discharge. NICU admission was withheld for 96%, 91%, 38% and 8% of neonates at 22, 23, 24 and 25 weeks of GA. This data is not surprising, as the French policy recommends non-intervention for the smallest babies and practices conform to the policy.
Six other European countries have similar non-treatment policies.2 National policies generally based their recommendations on local or national outcome data. But policies do not just reflect outcomes, they shape them. There is an iterative relationship between policies, guidelines and facts. Most other industrialised countries offer interventions at 23 weeks and, in those countries, many more such babies survive and most survivors do not have severe impairments.
Generally, paediatricians and policy makers favour treatments that improve survival rates. Treatment for extremely preterm infants is the exception to this general rule. There are three common arguments …
Related writing.
Why the Dutch Keep Pediatric Euthanasia Illegal
Pediatric euthanasia in The Netherlands has a unique legal status - it is illegal, openly practiced, and well-regulated. The most surprising part isn't the law that enabled this — it's what happened after.
The Tiniest Patients: Rethinking How We Decide
	When a baby is born at 22 or 23 weeks of pregnancy — half the normal gestational period — doctors and parents face one of the most agonizing decisions in all of medicine. Should they fight to keep the baby alive, knowing survival is u
When facts are not fixed: rethinking shared decision making at the margins of neonatal viability.
Parents and doctors face difficult decisions when a baby is born at the borderline of viability. Somehow, they must voice their values, shared concerns, and disagreements in a way that allows an initial decision about life-sustaining…
Survival After Court-Ordered Treatment Withdrawal
NR (as he is named in UK court documents) was born in 2020 with a malformed brain. He had, callosal agenesis, cortical dysgyria, dysplastic basal ganglia, a cleft lip and palate, and anopththalmia (no eyeballs). He was not expected to survi
About the author
John D. Lantos is a pediatrician and bioethicist writing on AI in medicine, neonatal intensive care, and end-of-life decisions. His essays appear in JAMA, JAMA Pediatrics, the Hastings Center Report, the New England Journal of Medicine, and Aeon. Read more about John.